BioCorRx partners with virtual reality center for naltrexone implant study

BioCorRx (OTC:BICX) said today that it partnered with the Virtual Reality Medical Center to conduct a study on the company’s long-lasting naltrexone implant.

BioCorRx’s recovery program consists of a long-lasting implant that delivers an opioid antagonist, naltrexone, which reduces physical cravings for alcohol and opioids. The recovery service also has a counseling program specifically designed to treat alcohol and substance abuse addictions in people receiving long-term naltrexone therapy.

Get the full story at our sister site, Drug Delivery Business News.

The post BioCorRx partners with virtual reality center for naltrexone implant study appeared first on MassDevice.

from MassDevice http://ift.tt/2rYQMu3